Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response.
about
Recognition of live phosphatidylserine-labeled tumor cells by dendritic cells: a novel approach to immunotherapy of skin cancerAdoptive immunotherapy for cancer: building on successChimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challengesAn efficient strategy to induce and maintain in vitro human T cells specific for autologous non-small cell lung carcinomaRoute of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control.Brain-specific angiogenesis inhibitor-1 expression in astrocytes and neurons: implications for its dual function as an apoptotic engulfment receptor.Remnants of suicidal cells fostering systemic autoaggression. Apoptosis in the origin and maintenance of autoimmunity.Human macrophages and dendritic cells can equally present MART-1 antigen to CD8(+) T cells after phagocytosis of gamma-irradiated melanoma cells.Induction of anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) and CD4(+) T-cell reactivity by dendritic cells loaded with HIV-1 X4-infected apoptotic cells.IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastomaBiological and clinical developments in melanoma vaccines.Profound tumor-specific Th2 bias in patients with malignant glioma.Cell-based therapy approaches using dying cells: from tumour immunotherapy to transplantation tolerance induction.Cancer/testis antigens: structural and immunobiological properties.Augmentation of antitumor immunity by fusions of ethanol-treated tumor cells and dendritic cells stimulated via dual TLRs through TGF-β1 blockade and IL-12p70 production.Tumor-specific shared antigenic peptides recognized by human T cells.Whole tumor antigen vaccines.Anti-CD3/anti-epidermal growth factor receptor-bispecific antibody retargeting of lymphocytes against human neoplastic keratinocytes in an autologous organotypic culture model.Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells.Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death.A review of vaccine clinical trials for non-small cell lung cancer.Whole tumor antigen vaccination using dendritic cells: comparison of RNA electroporation and pulsing with UV-irradiated tumor cells.Enhancing cancer immunotherapy by intracellular delivery of cell-penetrating peptides and stimulation of pattern-recognition receptor signaling.Peptide epitope identification for tumor-reactive CD4 T cells.Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approachesMechanisms of cellular communication through intercellular protein transfer.Fusions between dendritic cells and whole tumor cells as anticancer vaccines.Targeting the acute myeloid leukemic stem cell compartment by enhancing tumor cell-based vaccines.Alternate reading frame protein (F protein) of hepatitis C virus: paradoxical effects of activation and apoptosis on human dendritic cells lead to stimulation of T cells.Immune targets and neoantigens for cancer immunotherapy and precision medicine.Poly(I:C)-induced tumour cell death leads to DC maturation and Th1 activation.Dendritic and tumor cell fusions transduced with adenovirus encoding CD40L eradicate B-cell lymphoma and induce a Th17-type response.Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes.Gene expression imaging by enzymatic catalysis of a fluorescent probe via membrane-anchored beta-glucuronidase.Concurrent delivery of tumor antigens and activation signals to dendritic cells by irradiated CD40 ligand-transfected tumor cells resulted in efficient activation of specific CD8+ T cells.Dendritic cells efficiently cross-prime HLA class I-restricted cytolytic T lymphocytes when pulsed with both apoptotic and necrotic cells but not with soluble cell-derived lysates.Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment.Inhibition of sperm production in mice by annexin V microinjected into seminiferous tubules: possible etiology of phagocytic clearance of apoptotic spermatogenic cells and male infertility.Direct effects of polymyxin B on human dendritic cells maturation. The role of IkappaB-alpha/NF-kappaB and ERK1/2 pathways and adhesion.Cytokine secretion associated with the clearance of apoptotic bodies in renal cell carcinoma patients.
P2860
Q23918376-14CF2BFC-CC45-42CB-95AE-02B0A0CD36F0Q24546258-25BD8E21-E6F6-4044-B740-032F030BA8D3Q27025300-9C7DD97E-7FEA-4255-A65C-C288AA0FB045Q28749871-EBD14232-D478-4BDF-815F-52D6C9717E4EQ30311891-BE697BDE-A995-437B-8097-FB6E154F7385Q30426156-A260F6FB-7553-4561-B55A-4B646B27C947Q34004618-D73029FC-502B-48B1-ABA0-FAD0ADDB4E19Q34329143-91C37515-FFC4-48DB-A819-97F451E380ABQ34332462-1DFC6F9B-3CC2-4264-9B39-A210ABE0E5A3Q34447613-8723D671-D063-415D-94F7-528810491878Q34452007-168BEB6B-6129-4EA2-8873-77DA25138194Q34491734-2689FE9B-6694-475F-900E-79C9F9369595Q34560654-4D5C892F-6F34-4456-A23C-8DA0029843CDQ34568997-E17D3DB8-8C8E-4474-836E-8887373D6FD1Q34744217-0796043F-5626-43FE-B983-0C4A52DBB3E3Q35005926-232A6068-BF5F-4499-8D88-FF6057F38A5FQ35058235-742422B0-85A1-43B1-ACA4-26125E1415F9Q35750258-857748D7-3D89-4523-A8E9-3B9C783093E5Q36368308-F16D951E-2B94-414D-82A5-8BB28B04FA5AQ36403093-C9245157-FEAF-49D4-8D53-E44DB3865F7CQ36675454-FC096A6C-6C74-4E00-8A46-A95D4798BFB7Q36691357-D92F6AD0-D3A2-48F9-AE8C-869621ABFFFEQ37139813-45134654-463A-4F42-BB53-4467DE7A6DA8Q37171413-D87C3B21-9FF6-475C-B072-3823F577933FQ37470384-B91D784E-6EFA-437E-88C4-ABF95FAFF0D1Q37673276-CA408E79-D5B4-405D-AD0C-30297F61A24CQ38114095-F8438F52-E7F8-4ACB-A163-9F29E989456FQ38125532-A764B154-83A0-465C-BBEA-64814AA1881CQ39029386-B329F185-C586-497E-8928-C7558047AC17Q39057617-38CEAED0-5A20-4BD8-952A-2F71D14BF5ADQ39520906-4D0CB5B8-2E39-44C9-8D21-E99D3CB80B68Q39763286-D6973C86-9C57-410F-A9A8-2FBDED449F46Q40143132-2A62DBE8-39F1-4A67-995F-1EB65D5CFA2AQ40181563-23EA03C6-9679-4438-98BB-6EB2B2CDFE52Q40546795-BFF05471-D865-4167-AE4F-F73A45670EDFQ40839498-91BFBC5F-9D85-4409-8349-418C77610B4CQ43773475-8B019FA4-1B6E-4F9A-BF5B-2384C3A32B5AQ44023201-805F2F26-4D3E-41BA-8370-8A3071A5DA72Q45238580-B7B86136-345C-4B63-8AF8-9B2809AA5785Q45875973-AC1A0ED1-CE56-4EA2-85E8-C4062F9B5262
P2860
Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Dendritic cells acquire the MA ...... I-restricted T cell response.
@ast
Dendritic cells acquire the MA ...... I-restricted T cell response.
@en
type
label
Dendritic cells acquire the MA ...... I-restricted T cell response.
@ast
Dendritic cells acquire the MA ...... I-restricted T cell response.
@en
prefLabel
Dendritic cells acquire the MA ...... I-restricted T cell response.
@ast
Dendritic cells acquire the MA ...... I-restricted T cell response.
@en
P2093
P2860
P50
P356
P1476
Dendritic cells acquire the MA ...... I-restricted T cell response.
@en
P2093
P2860
P304
P356
10.1073/PNAS.040540197
P407
P577
2000-02-01T00:00:00Z